-
22m 43sPart 1 | Session 1 What's Hot at TCT 2021: View from the Thoraxcenter
-
22m 33sPart 1 | Session 2 View from the Thoraxcenter: TCT 21 Late-breaking Science Wrap Up
-
10m 32s
-
4m 40sPart 2 | Session 2 iFR-SWEDEHEART: No Difference in Outcome at 5-yrs of iFR vs FFR
-
8m 19s
-
7m 32sPart 2 | Session 4 CHOICE-CLOSURE: Plug-based Vs Suture-based Large-bore Vascular Closure
-
7m 27sPart 2 | Session 5 TRISCEND II: 6Mo Outcomes Show TR Reduction in Majority of Patients
-
8m 8sPart 2 | Session 6 SCB Shows Similar Angiographic Outcomes to Paclitaxel DCB
-
3m 37sPart 2 | Session 7 Intrepid TMVR: Results Show Improved NYHA Class at 30 Days
-
6m 43s
-
4m 44s
-
4m 28sPart 2 | Session 10 BIO-RESORT: 5Y Outcomes
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provide a concise and insightful preview of the late-breaking science presented at TCT 2021.
Short, accessible Expert Interviews will be available conducted with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Faculty Biographies
David Kandzari
Director of Interventional Cardiology and Chief Scientific Officer
Dr David Kandzari obtained his undergraduate degree from Duke University School of Medicine then completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences.
Dr Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 150 studies, book chapters and scientific reviews. Dr Kandzari is board certified in internal medicine and cardiovascular diseases and is certified by the Board of Interventional Cardiology. He specializes in interventional cardiology, peripheral arterial disease and cardiovascular medicine. His…